October 14, 2025

agilon health, inc. (AGL) Stock Analysis: Exploring 36% Potential Upside Amidst Healthcare Challenges

agilon health, inc. (NYSE: AGL) has been capturing the attention of investors with its unique approach to healthcare services for seniors through a network of primary care physicians across the..

MannKind Corporation (MNKD) Stock Analysis: Assessing a 103% Potential Upside in the Biotech Sector

MannKind Corporation (NASDAQ: MNKD), a leading player in the biotechnology sector, has captured investor attention with its promising therapeutic products targeting endocrine and orphan lung diseases. With a market capitalization..

Indivior PLC (INDV) Stock Analysis: Evaluating a 22% Potential Upside in Healthcare

Indivior PLC (INDV), a prominent player in the healthcare sector, holds a pivotal position within the specialty and generic drug manufacturing industry. With a market cap of $2.98 billion and..

Harrow, Inc. (HROW) Stock Analysis: Eyeing a 75.84% Upside in the Healthcare Sector

Harrow, Inc. (NASDAQ: HROW), a Nashville-based pharmaceutical company, has caught the eye of investors with its robust potential upside of 75.84%, according to recent analyst ratings. Specializing in ophthalmic pharmaceutical..

Pacira BioSciences, Inc. (PCRX) Investor Outlook: A 30% Upside Potential Amidst Healthcare Innovation

Pacira BioSciences, Inc. (NASDAQ: PCRX) presents a compelling case for investors with its innovative approach to pain management solutions and a significant upside potential of 30.28% based on analyst projections...

Recursion Pharmaceuticals (RXRX) Investor Outlook: Exploring a 16.94% Potential Upside in the Biotech Sector

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX), a clinical-stage biotechnology company headquartered in Salt Lake City, Utah, is making waves in the healthcare sector with its innovative approach to drug discovery. With..

GeneDx Holdings Corp. (WGS): Investor Outlook Highlights Robust Revenue Growth and Positive Analyst Ratings

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, is capturing attention with its impressive revenue growth and strong analyst endorsements. With a market capitalization of $3.47..

Dynavax Technologies Corporation (DVAX): Investor Outlook Reveals 127.77% Potential Upside

Investors seeking opportunities in the healthcare sector might find Dynavax Technologies Corporation (NASDAQ: DVAX) an intriguing option. With a market capitalization of $1.17 billion, this biopharmaceutical company is making waves..

BioLife Solutions, Inc. (BLFS) Stock Analysis: Strong Buy Ratings Signal a Promising 14% Upside Potential

For investors eyeing opportunities within the healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) stands out as a promising candidate, particularly in the burgeoning field of cell and gene therapy (CGT)...

Enovis Corporation (ENOV) Stock Analysis: A Lucrative 67% Upside Potential in Medical Device Innovation

Enovis Corporation (NYSE: ENOV), a prominent player in the healthcare sector, stands at an intriguing juncture for investors. With its focus on innovative medical device solutions, the company presents a..

Vera Therapeutics, Inc. (VERA): Investor Outlook on a 109% Upside Potential in the Biotech Sector

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning player in the biotechnology sector, is capturing investor attention with its promising pipeline focused on transformative treatments for serious immunological diseases. With a..

Mesoblast Limited (MESO) Stock Analysis: A Biotech Titan with 92.94% Upside Potential

Mesoblast Limited (NASDAQ: MESO), a pioneering player in the biotechnology sector, is currently captivating the attention of investors with its innovative approach to regenerative medicine. With a market capitalization of..

The Pennant Group, Inc. (PNTG): Potential Upside of 40% Ignites Investor Interest

The Pennant Group, Inc. (NASDAQ: PNTG) is capturing the attention of investors with its remarkable potential upside of 40.06%, as suggested by current analyst ratings. Operating in the dynamic healthcare..

Kestra Medical Technologies, Lt (KMTS) Stock Analysis: A 20% Upside Potential in the Healthcare Sector

Kestra Medical Technologies, Ltd (KMTS), a burgeoning player in the healthcare sector, has garnered significant attention from investors, particularly due to its promising growth potential and innovative approach to cardiovascular..

ANI Pharmaceuticals, Inc. (ANIP): Investor Outlook with 20% Potential Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a specialty and generic drug manufacturer, is drawing significant investor attention with its promising 20.33% potential upside. Headquartered in Baudette, Minnesota, the company operates in..

10x Genomics, Inc. (TXG) Stock Analysis: Unpacking a 29% Potential Upside in the Healthcare Sector

Investors looking to capitalize on the innovative edge of the healthcare sector might find 10x Genomics, Inc. (NASDAQ: TXG) an intriguing opportunity. This Pleasanton, California-based life science technology company is..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Healthcare Innovator with 22.64% Potential Upside

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is emerging as a strong contender in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.93 billion,..

Select Medical Holdings Corp (SEM) Stock Analysis: Strong Buy Ratings Signal 36% Upside Potential

Select Medical Holdings Corporation (NYSE: SEM), known for its extensive network of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics, has been making waves in the healthcare sector...

Certara, Inc. (CERT) Stock Analysis: Unveiling a 20% Upside Potential in Healthcare Innovation

Certara, Inc. (NASDAQ: CERT), a prominent player in the healthcare sector, is making waves in the health information services industry with its cutting-edge technology-enabled services and software products. As a..

Tarsus Pharmaceuticals (TARS) Stock Analysis: A 9% Upside with Strong Buy Ratings

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) is drawing significant attention in the biotechnology sector, particularly due to its innovative focus on eye care therapeutics. The Irvine, California-based company is emerging as..

Search

Funds

October 14, 2025

Search

Funds

October 14, 2025

FTSE 100

Funds